vivoPHIX and genoPHIX are patented next generation tissue fixatives and biomolecule stabilisers, microbicide and are compatible with all biological sample types, both liquid and solid. vivoPHIX has been tested by over 240 leading researchers worldwide. Please ask for our tissue dissociation protocols for single-cell multi-omic applications including scRNA-seq.
vivoPHIX and genoPHIX are patented next generation tissue fixatives, biomolecule stabilisers, with microbicide activity and are compatible with all biological sample types both liquid and solid. Please ask about our tissue dissociation protocols for creating single-cells for multi-omics including scRNA-seq. vivoPHIX and genoPHIX have been tested by over 240 leading academics worldwide.
RNAssist and Rapid Labs Agree on Manufacturing and
Cambridge and Glasgow, UK. 23rd January 2020 – RNA
If you would like to receive news about RNAssist and associated products, evaluate our ground-breaking fixative and stabiliser, carryout tissue dissociation and single-cell preparation or would simply like to exchange comments and results with more than 180 other members of the RNAssist User Community please send a message. We look forward to meeting you!
This non-toxic formalin-free tissue fixative ensures the preservation of both tissue histomorphology and biomolecules. RNAssist prevents the degradation of proteins, DNA, RNA and mRNA. When compared to products such as RNAlater ®, PAXgene Tissue Systems or Allprotect ® Tissue Reagent, RNA demonstrated high-quality RNA stabilization and protection in the context of long-term tissue storage and archival . Designed for room temperature use, RNAssist is compatible with routine paraffin-embedding procedure, pathology staining – (H&E, immunohistochemistry (IHC) , in situ hybridization (IS) – and molecular analysis : RT-PCR, WB, next-geneneration sequencing, …